Thrivent Financial for Lutherans raised its position in shares of Silicon Laboratories Inc. (NASDAQ:SLAB - Free Report) by 10.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 131,548 shares of the semiconductor company's stock after purchasing an additional 12,435 shares during the quarter. Thrivent Financial for Lutherans owned 0.41% of Silicon Laboratories worth $15,203,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently modified their holdings of the company. Capital Research Global Investors increased its stake in shares of Silicon Laboratories by 29.9% in the first quarter. Capital Research Global Investors now owns 1,217,939 shares of the semiconductor company's stock worth $175,042,000 after acquiring an additional 280,000 shares during the period. Clearbridge Investments LLC raised its stake in shares of Silicon Laboratories by 84.0% during the 2nd quarter. Clearbridge Investments LLC now owns 273,776 shares of the semiconductor company's stock valued at $30,288,000 after buying an additional 125,022 shares during the last quarter. American Century Companies Inc. lifted its holdings in shares of Silicon Laboratories by 29.5% in the 2nd quarter. American Century Companies Inc. now owns 316,407 shares of the semiconductor company's stock valued at $35,004,000 after buying an additional 72,138 shares during the period. Van Berkom & Associates Inc. boosted its stake in shares of Silicon Laboratories by 8.4% in the second quarter. Van Berkom & Associates Inc. now owns 609,232 shares of the semiconductor company's stock worth $67,399,000 after buying an additional 47,058 shares during the last quarter. Finally, Davidson Investment Advisors grew its holdings in Silicon Laboratories by 36.7% during the second quarter. Davidson Investment Advisors now owns 131,453 shares of the semiconductor company's stock worth $14,543,000 after acquiring an additional 35,317 shares during the period.
Wall Street Analyst Weigh In
SLAB has been the subject of a number of analyst reports. Barclays decreased their price target on Silicon Laboratories from $120.00 to $75.00 and set an "equal weight" rating for the company in a report on Tuesday, November 5th. Stifel Nicolaus cut their price objective on shares of Silicon Laboratories from $160.00 to $135.00 and set a "buy" rating for the company in a report on Tuesday, November 5th. Benchmark reaffirmed a "hold" rating on shares of Silicon Laboratories in a research note on Tuesday, November 5th. JPMorgan Chase & Co. cut their price target on shares of Silicon Laboratories from $150.00 to $135.00 and set an "overweight" rating for the company in a report on Tuesday, November 5th. Finally, Morgan Stanley decreased their price objective on shares of Silicon Laboratories from $123.00 to $97.00 and set an "equal weight" rating on the stock in a report on Tuesday, November 5th. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $121.50.
Read Our Latest Analysis on Silicon Laboratories
Insider Activity at Silicon Laboratories
In other news, SVP Brandon Tolany sold 845 shares of the company's stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $115.00, for a total value of $97,175.00. Following the transaction, the senior vice president now owns 43,615 shares of the company's stock, valued at $5,015,725. This represents a 1.90 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.72% of the stock is currently owned by insiders.
Silicon Laboratories Stock Up 0.5 %
NASDAQ:SLAB traded up $0.54 during trading hours on Thursday, hitting $102.09. The company had a trading volume of 6,289 shares, compared to its average volume of 297,173. Silicon Laboratories Inc. has a 1 year low of $94.00 and a 1 year high of $154.91. The company has a 50-day moving average of $111.29 and a 200 day moving average of $114.39.
Silicon Laboratories (NASDAQ:SLAB - Get Free Report) last released its quarterly earnings data on Monday, November 4th. The semiconductor company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.20) by $0.07. The firm had revenue of $166.00 million during the quarter, compared to analysts' expectations of $165.50 million. Silicon Laboratories had a negative net margin of 46.93% and a negative return on equity of 12.60%. Silicon Laboratories's revenue was down 18.5% compared to the same quarter last year. During the same period last year, the business earned $0.48 earnings per share. On average, research analysts expect that Silicon Laboratories Inc. will post -3.56 earnings per share for the current year.
Silicon Laboratories Company Profile
(
Free Report)
Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.
Recommended Stories
Before you consider Silicon Laboratories, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Silicon Laboratories wasn't on the list.
While Silicon Laboratories currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report